Page 3 - Therapeutics Development News Today

CONGRESS - House Republicans Still Unable to Elect New Speaker. As of publication of this newsletter, the House has held three roll call votes this week to elect a new...

/PRNewswire/ -- The "Emerging Landscape of Targeted Protein Degradation Therapeutics" report has been added to ResearchAndMarkets.coms offering. Advancing...

– Project ‘NADER’ is intended to span multiplephases, starting from mapping rare diseases in the UAE and wider region through innovative risk assessment algorithms, and moving towards clinical trials with

UAE-based Burjeel Holdings and US-based BridgeBio Pharma have announced a new project to revolutionise the field of early diagnosis and treatment of rare diseases or disorders in the UAE and the region.

Burjeel Holdings, one of the largest healthcare providers in

/PRNewswire/ -- The "Extracellular Vesicles 2023: Drug Delivery, Biologics & Therapeutics" conference has been added to ResearchAndMarkets.coms offering....

/PRNewswire/ -- The "Extracellular Vesicles 2023: Technologies, Biomarker Cargo & Diagnostics" conference has been added to ResearchAndMarkets.coms offering....

First clinical results to be presented at the AACR Annual Meeting 2023 showed 23ME-00610 demonstrated an acceptable safety and tolerability profile, with favorable pharmacokinetics and peripheral... | April 14, 2023

23andMe Announces Phase 1 Results from the First-in-Human Phase 1/2a Study of 23ME-00610, an Investigational Antibody Targeting CD200R1 ● First clinical... | April 14, 2023

DUBLIN--(BUSINESS WIRE)--The "mRNA Vaccines and Therapeutics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.The global mRNA vaccines and therapeutics market size reached US$ 56.1 Billion in 2022. Looking forward, the...